EGAN vs RNA
Comparison between eGain Corp (EGAN, Company) and Atrium Therapeutics Inc (RNA, Company).
EGAN is from the Technology sector, while RNA is from the Healthcare sector.
EGAN vs RNA - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
EGAN
$199M
Winner
RNA
$200M
Max Drawdown
EGAN
99.97%
Winner
RNA
30.17%
Sharpe Ratio
Winner
EGAN
0.60
RNA
-1.04
5Y Beta
EGAN
1.20
Winner
RNA
0.95
Industry
EGAN
Software - Application
RNA
Biotechnology
P/E Ratio
EGAN
25.88
RNA
N/A
Forward P/E
EGAN
16.37
RNA
N/A
PEG Ratio
EGAN
0.29
Winner
RNA
0.00
5Y EPS CAGR
EGAN
2.46%
RNA
N/A
Debt to Equity
EGAN
0.00%
RNA
0.00%
Free Cash Flow Yield
Winner
EGAN
6.86%
RNA
0.00%
P/S Ratio
Winner
EGAN
2.16
RNA
5.51
P/B Ratio
EGAN
2.16
Winner
RNA
0.86
EGAN vs RNA - Historical Returns
Returns include dividend reinvestment.
1M
Winner
EGAN
+7.69%
RNA
-5.86%
3M
EGAN
-17.46%
Winner
RNA
-14.92%
6M
EGAN
-28.24%
RNA
N/A
1Y
EGAN
+21.44%
RNA
N/A
5Y(CAGR)
EGAN
-7.42%
RNA
N/A
10Y(CAGR)
EGAN
+8.41%
RNA
N/A
Max(CAGR)
Winner
EGAN
-12.78%
RNA
-45.78%
EGAN vs RNA - Annual Returns (1999 - 2026)
Returns include dividend reinvestment.
| Year | EGAN | RNA |
|---|---|---|
| 2026 | -28.10% | -16.14% |
| 2025 | +67.59% | N/A |
| 2024 | -24.39% | N/A |
| 2023 | -9.26% | N/A |
| 2022 | -9.97% | N/A |
| 2021 | -14.85% | N/A |
| 2020 | +46.16% | N/A |
| 2019 | +17.86% | N/A |
| 2018 | +20.55% | N/A |
| 2017 | +156.10% | N/A |
| 2016 | -48.28% | N/A |
| 2015 | -16.80% | N/A |
| 2014 | -49.36% | N/A |
| 2013 | +130.11% | N/A |
| 2012 | -36.62% | N/A |
| 2011 | +475.83% | N/A |
| 2010 | +29.81% | N/A |
| 2009 | +258.62% | N/A |
| 2008 | -58.33% | N/A |
| 2007 | -64.57% | N/A |
| 2006 | +81.94% | N/A |
| 2005 | -30.77% | N/A |
| 2004 | -53.95% | N/A |
| 2003 | -2.38% | N/A |
| 2002 | -86.27% | N/A |
| 2001 | -57.32% | N/A |
| 2000 | -91.51% | N/A |
| 1999 | +33.63% | N/A |
EGAN vs RNA Drawdown Comparison
The maximum drawdown for EGAN was -99.97%, occurring on Jun 18, 2009. This drawdown has not yet recovered.
The maximum drawdown for RNA was -30.17%, occurring on Jun 8, 2026. This drawdown has not yet recovered.
The current EGAN drawdown is -98.92%. The current RNA drawdown is -25.21%.
| Rank | EGAN | RNA |
|---|---|---|
| #1 | -99.97% Mar 3, 2000 - Jun 18, 2009 | -30.17% Mar 4, 2026 - Jun 8, 2026 |
| #2 | -53.68% Dec 8, 1999 - Mar 1, 2000 | N/A |
| #3 | -16.65% Nov 18, 1999 - Dec 2, 1999 | N/A |
| #4 | -14.29% Nov 8, 1999 - Nov 18, 1999 | N/A |
| #5 | -9.74% Nov 3, 1999 - Nov 8, 1999 | N/A |
| #6 | -6.18% Dec 2, 1999 - Dec 6, 1999 | N/A |
Correlation
Correlation between EGAN and RNA is 0.97 which considered as a very strong positive correlation - the stocks move almost identically together.
0.97
-101
Select Stocks to Compare
Popular: EGAN vs SPYRNA vs SPY
More Comparisons
Compare with similar stocks